HLA-DR2 and Sleep Onset REM Periods in Depression
To the Editor:
Virtually all patients with narcolepsy/cataplexy are HLA-DR2 positive, in contrast to an approximately 25% incidence of this human leukocyte antigen (HLA) in the general population (cf. Honda and Juji !988). Given the close association between narcolepsy and HLA-DR2 on the one hand, and the most typical sleep alteration, i.e., sleep onset rapid eye movement (REIvl) periods (:/OREMPs) in narcoleptic patients on the other (Vogel 1960) . the question arises as to whether there is a direct link between DR2 and certain features of sleep structure. The aim of the present study was, therefore, to look for HLA-DR2 incidence in depression, an illness that shares--even though less regularly--tbe feature of shortened REM latency with narcolepsy (Coble et al 1981) .
Recently Montplaisir et al (1990) failed Lo show an increased occurrence of HLA-DR2 in unil.~,olar depression, as against Riemann et al. (1988) , wko in a pilot study, reported 4 of 7 patients with a ,valor depressive disorder and at least one SOREMP &:ring night sleep to be HLA-DR2 positive. A possible explanation for these conflicting results could be a depression-independent impact o~ HLA-DR2 on sleep sh~cture. We, therefore, examined the frequency of HLA-DR2 in a larger sample of depressed patients, res*cfing our post hoc examination to those depressives who displayed SOREMPs in standard night polysomno~raphy ~md, thereby, share this typical sleep Sixteen patients (8 men and 8 women) with a major depressive disorder/endogenous subtype (Research Diagnostic Criteria, RDC) (Spitzer et al 1978) were investigated, all giving informed consent. The mean age (_+SD) was 47.3 ± 7.5 years. ,'~i~een of the patients under investigation displayed a SOREMP (REM sleep latency after first epoch $2 sleep <15 min) at least once during night sleep recordings, whereas the other 3 patients exhibited REM latencies of 18, 21, and 23 min.
On the average, one or two nights of baseline sleep were recorded for each patient, applying standard night sonmopolygraphy (EEG, EMG, EOG). PatieWs were free of any psychoactive medication at least 1 week prior to sleep recordings; urinary drug monitoring was carried out ~gularly. Sleep recordings and analysis were carried out according to the guidelines proposed by Rechtschaffen and Kales (1968) . The following sleep parameters were determined: sleep period time (SPT); sleep onset latency (min, defined as first epoch $2 sleep); REM sleep latency (rain, defined as the time interval between sleep onset and REM start); sleep efficiency (%); and the percentages for gEM and slow wave sleep ($3 + $4), both based on SFr. HLA-typing was determined by duplicate serological testing and by reslrictioa fragment length polymorphism (RFLP) analysis (cf. Geisler and Albert 1989) .
Concerning our target variable, mean REM latency (+ SD) was 10.6 _ 6.4 nfia. An~ysis of ",he other sleep parameters revealed a low sleep efficiency (72.1% + 20.1%), a rather long sleep onset latency (27.8 min +_ 18.5 min), a normal amount ef ~.EM sleep (23.6% -+ 9.7%), and a low percentage of slowwave sleep (6.8 -+ 6.7% SPT). HLA typing reve~ed an incidence of HLA-DR2 cf25% (or 4 of 16 patients under investigation).
In our subgroup of depressed patients, showing at least one ~OP.~,MP during polyg~ap,hic sleep re-cording, the incidence of HLA-DR2 was only 25%. This observation strongly underlines the findings of Mentplaisk et al (!990 ) that the frequency of HLA-DR2 in depressed patients in general is not different from that found in normal controls. Furthermore, our results clearly refute the assumption of a direct immunogenetic association between abbreviated REMsleep latency (including SOREI:dPs) and HLA-DR2. Finally, the present results are in agreement with previous findings showing that REM latency in norreal subjects does not correlate with the HLA-DR2 haplotype (Schulz et al 1987) .
From this evidence we conclude that the presence of HLA-DR2 and an increased propensity toward SOREMPs are two independent features. This suggests that HLA-DR2 may be instead associated with cataplexy, a pathophysiological event that is peculiar to narcolepsy (Guilleminault 1976) , and ttmt has never been reported for depressives or other subjects ~,ith shortened REM latency. 
